Labcorp EVP granted options and RSUs

Labcorp Holdings Inc. executive Anita Z. Graham, EVP and Chief Human Resources Officer, reported equity awards granted on February 10, 2026.

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Anita Z. Graham, EVP and Chief Human Resources Officer, reported equity awards granted on February 10, 2026. She received non-qualified stock options for 4,100 shares of common stock with an exercise price of $284.5 per share, vesting in three equal annual installments beginning that date. She was also granted 1,360 Restricted Stock Units, each representing one share of common stock, which vest in three equal annual installments beginning on February 10, 2027. Following this award, she holds 2,757 Restricted Stock Units in total.

Insider Trade Summary

Grant/Award: 5,460 shares

Grant/Award 2 txns

Insider GRAHAM ANITA Z

Role EVP, CHRO

Type	Security	Shares	Price	Value
Grant/Award	Non-qualified Stock Options	4,100	$0.00	$0.00
Grant/Award	Restricted Stock Unit	1,360	$0.00	$0.00

Holdings After Transaction: Non-qualified Stock Options — 4,100 contracts (Direct); Restricted Stock Unit — 2,757 contracts (Direct)

Footnotes (5)

1. F1. Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.
2. F2. The option vests in three equal annual installments beginning on the date reflected in this column.
3. F3. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
4. F4. The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.
5. F5. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LH executive Anita Z. Graham report?

Anita Z. Graham reported equity awards granted on February 10, 2026. She received 4,100 non-qualified stock options and 1,360 Restricted Stock Units in Labcorp common stock, both vesting in three annual installments under the company’s 2025 Omnibus Incentive Plan.

How many stock options were granted to LH EVP, CHRO Anita Z. Graham?

Anita Z. Graham was granted 4,100 non-qualified stock options on February 10, 2026. These options allow her to buy Labcorp common shares at an exercise price of $284.5, vesting in three equal annual installments starting on the grant date.

What are the terms of Anita Z. Graham’s Restricted Stock Units at LH?

She received 1,360 Restricted Stock Units on February 10, 2026. Each unit represents the right to receive one Labcorp common share, vesting in three equal annual installments beginning on February 10, 2027, subject to continued service and plan terms.

How many Restricted Stock Units does Anita Z. Graham hold after this Form 4?

After the February 10, 2026 grant, Anita Z. Graham beneficially owns 2,757 Restricted Stock Units. This figure represents the aggregate number of RSUs credited to her under Labcorp’s equity programs, as disclosed in the filing’s explanatory footnote.

When do Anita Z. Graham’s Labcorp stock options start vesting?

The non-qualified stock options granted to Anita Z. Graham begin vesting on February 10, 2026. They vest in three equal annual installments from that date, aligning the award with multi-year retention and performance incentives under Labcorp’s 2025 Omnibus Incentive Plan.

What is the exercise price of Anita Z. Graham’s new Labcorp stock options?

The non-qualified stock options granted to Anita Z. Graham have an exercise price of $284.5 per share. This is the price she must pay to purchase each Labcorp common share if and when she exercises vested options in the future.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 03:35 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GRAHAM ANITA Z

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CHRO

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Options(1)	$284.5	02/10/2026		A		4,100		02/10/2027(2)	02/09/2036	Common Stock	4,100	$0	4,100	D
Restricted Stock Unit	(3)	02/10/2026		A		1,360		(4)	(4)	Common Stock	1,360	$0	2,757(5)	D

Explanation of Responses:

1. Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.

2. The option vests in three equal annual installments beginning on the date reflected in this column.

3. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

4. The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.

5. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Anita Z. Graham	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.